Skip to main content
Article thumbnail
Location of Repository

Expression, intracellular targeting and purification of HIV Nef variants in tobacco cells\ud

By Carla Marusic, James Nuttall, Giampaolo Buriani, Chiara Lico, Raffaele Lombardi, Selene Baschieri, Eugenio Benvenuto and Lorenzo Frigerio


Background\ud Plants may represent excellent alternatives to classical heterologous protein expression systems, especially for the production of biopharmaceuticals and vaccine components. Modern vaccines are becoming increasingly complex, with the incorporation of multiple antigens. Approaches towards developing an HIV vaccine appear to confirm this, with a combination of candidate antigens. Among these, HIV-Nef is considered a promising target for vaccine development because immune responses directed against this viral protein could help to control the initial steps of viral infection and to reduce viral loads and spreading. Two isoforms of Nef protein can be found in cells: a full-length N-terminal myristoylated form (p27, 27 kDa) and a truncated form (p25, 25 kDa). Here we report the expression and purification of HIV Nef from transgenic tobacco.\ud \ud Results\ud We designed constructs to direct the expression of p25 and p27 Nef to either the cytosol or the secretory pathway. We tested these constructs by transient expression in tobacco protoplasts. Cytosolic Nef polypeptides are correctly synthesised and are stable. The same is not true for Nef polypeptides targeted to the secretory pathway by virtue of a signal peptide. We therefore generated transgenic plants expressing cytosolic, full length or truncated Nef. Expression levels were variable, but in some lines they averaged 0.7% of total soluble proteins. Hexahistidine-tagged Nef was easily purified from transgenic tissue in a one-step procedure.\ud \ud Conclusion\ud We have shown that transient expression can help to rapidly determine the best cellular compartment for accumulation of a recombinant protein. We have successfully expressed HIV Nef polypeptides in the cytosol of transgenic tobacco plants. The proteins can easily be purified from transgenic tissue.\ud \u

Topics: QR355
Publisher: BioMed Central Ltd.
Year: 2007
OAI identifier:

Suggested articles


  1. (1999). Apoplastic and cytosolic expression of full-size antibodies and antibody fragments in Nicotiana tabacum. Transgenic Res
  2. (2005). Ceriotti A: Endoplasmic reticulum-associated degradation of ricin A chain has unique and plant-specific features. Plant Physiol doi
  3. (1998). Compartment-specific accumulation of recombinant immunoglobulins in plant cells: an essential tool for antibody production and immunomodulation of physiological functions and pathogen activity. Plant Mol Biol doi
  4. (1998). D: HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature
  5. (1990). Deblaere R: Protein secretion in plant cells can occur via a default pathway. Plant Cell doi
  6. (2003). E: Engineering Stable Cytoplasmic Intrabodies with Designed Specificity. doi
  7. (2003). Frigerio L: The C-terminal extension of a hybrid immunoglobulin A/G heavy chain is responsible for its Golgi-mediated sorting to the vacuole. Molecular Biology of the Cell doi
  8. (2006). Gerngross TU: Humanization of Yeast to Produce Complex Terminally Sialylated Glycoproteins. Science doi
  9. (2006). Gerngross TU: Optimization of humanized IgGs in glycoengineered Pichia pastoris. Nat Biotech doi
  10. (1995). Higgins TJV: A biotechnological approach to improving the nutritive value of alfalfa.
  11. (2002). HIV Regulatory and Accessory Proteins: New Targets for Vaccine Development. DNA and Cell Biology doi
  12. (1994). HR: Stability and proteolytic domains of Nef protein from human immunodeficiency virus (HIV) type 1. doi
  13. (1999). HR: Structure of the anchor-domain of myristoylated and non-myristoylated HIV-1 Nef protein. doi
  14. (2003). HS: A plant signal peptide-hepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells. PNAS doi
  15. (2003). I: Anti-herbicide singlechain antibody expression confers herbicide tolerance in transgenic plants. doi
  16. (2003). JA: Maize (Zea mays)-derived bovine trypsin: Characterization of the first large-scale, commercial protein product from transgenic plants. Biotechnol Appl Biochem doi
  17. (2006). JKC: HIV-1 p24-immunoglobulin fusion molecule: a new strategy for plant-based protein production. Plant Biotechnology Journal doi
  18. (1994). Large-scale production and characterization of recombinant human immunodeficiency virus type 1 Nef. doi
  19. (2001). Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends in Plant Science doi
  20. (2005). Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants. EMBO Rep doi
  21. (2000). Okuyama H: Lipid-linked proteins of plants.
  22. (2005). Opportunities for recombinant antigen and antibody expression in transgenic plants-technology assessment. Vaccine doi
  23. (1990). Panet A: Expression and biochemical characterization of human immunodeficiency virus type 1 nef gene product.
  24. (2005). Panstruga R: Conserved ERAD-like quality control of a plant polytopic membrane protein. Plant Cell doi
  25. (1989). Pease LR: Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene doi
  26. (2005). Plant based HIV-1 vaccine candidate: Tat protein produced in spinach. Vaccine doi
  27. (2004). Predicting N-terminal myristoylation sites in plant proteins.
  28. (1997). Regulated expression vectors demonstrate cell-type-specific sensitivity to human immunodeficiency virus type 1 Nef-induced cytostasis.
  29. (2006). Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity. Aids doi
  30. (2001). Robert-Guroff M: Deletion of N-terminal myristoylation site of HIV doi
  31. (1998). Roberts LM: Free ricin A chain, proricin and native toxin have different cellular fates when expressed in tobacco protoplasts. doi
  32. (2001). Roberts LM: Ricin A chain without its partner B chain is degraded after retrotranslocation from the endoplasmic reticulum to the cytosol in plant cells. doi
  33. (1985). RT: Transgenic plants. Cold Spring Harb Symp Quant Biol
  34. (1993). Swanstrom R: Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo.
  35. (2004). T: A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection . AIDS doi
  36. (1995). T: Generation and assembly of secretory antibodies in plants. Science doi
  37. (2002). The 5'-leader of tobacco mosaic virus promotes translation through enhanced recruitment of eIF4F. Nucleic Acids Res doi
  38. (2003). The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet doi
  39. (1997). Vitale A: Protein quality control along the route to the plant vacuole. Plant Cell doi
  40. (2003). Wolf DH: Waste disposal in plants: where and how? Trends Plant Sci doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.